Geneva Partners’s iShares iBonds Dec 2021 Term Corporate ETF IBDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-9,197
Closed -$230K 114
2020
Q3
$230K Buy
+9,197
New +$231K 0.14% 77
2018
Q4
Sell
-27,160
Closed -$662K 93
2018
Q3
$662K Sell
27,160
-35,975
-57% -$876K 0.51% 59
2018
Q2
$1.54M Sell
63,135
-6,980
-10% -$170K 1.22% 28
2018
Q1
$1.72M Buy
70,115
+30,276
+76% +$744K 1.41% 26
2017
Q4
$998K Hold
39,839
0.75% 51
2017
Q3
$998K Buy
+39,839
New +$998K 0.79% 46
2016
Q2
$915K Buy
+36,630
New +$919K 0.82% 45

Other funds holding IBDM

Geneva Partners's IBDM Position: Q4 2020 in Review

Geneva Partners sold out of iShares iBonds Dec 2021 Term Corporate ETF (IBDM) in Q4 2020, closing a stake of 9,197 shares — an estimated $230K sold.

Geneva Partners first reported a position in IBDM in Q2 2016 and held it in 7 quarters. The position peaked at $1.72M in Q1 2018. 206 funds tracked by Wall St. Rank hold IBDM as of Q4 2020.

  • Geneva Partners reported no remaining iShares iBonds Dec 2021 Term Corporate ETF position as of Q4 2020 after selling out during the quarter.
  • Geneva Partners sold 9,197 iShares iBonds Dec 2021 Term Corporate ETF shares in Q4 2020, an estimated $230K.
  • Geneva Partners first reported a position in iShares iBonds Dec 2021 Term Corporate ETF in Q2 2016 and held it in 7 quarters.
  • Geneva Partners's iShares iBonds Dec 2021 Term Corporate ETF position peaked at $1.72M in Q1 2018.
  • 206 funds tracked by Wall St. Rank held iShares iBonds Dec 2021 Term Corporate ETF as of Q4 2020.

Based on Geneva Partners's 13F filing for Q4 2020, filed 1 Feb 2021.